This product is a broad-spectrum antibacterial agent, with bactericidal effect at high concentration. It has antibacterial effect on Streptococcus pneumoniae, hemolytic Streptococcus, Streptococcus viridans and some Staphylococci, Clostridium perfringens, Bacillus anthracis, Yersinia pestis, Corynebacterium diphtheriae, Clostridium tetani, Brucella, Haemophilus influenzae, Campylobacter, Vibrio cholerae, etc. It also has inhibitory effect on Rickettsia, Mycoplasma, Chlamydia, Spirochete, and some protozoa. It has better effect on Gram-positive bacteria than Gram-negative bacteria, but Enterococcus is resistant to it. It binds to the A position of the 30S subunit of the bacterial ribosome, preventing the connection of aminoacyl-tRNA at this position, thereby inhibiting the growth of peptide chains and affecting the synthesis of bacterial proteins.

This product is a broad-spectrum antibacterial agent, with bactericidal effect at high concentrations. It has certain antibacterial effects on Streptococcus pneumoniae, hemolytic Streptococcus, Streptococcus viridans and some Staphylococci, Clostridium perfringens, Bacillus anthracis, Yersinia pestis, Corynebacterium diphtheriae, Clostridium tetani, Brucella, Haemophilus influenzae, Campylobacter, Vibrio cholerae, and also has inhibitory effects on Rickettsia, Mycoplasma, Chlamydia, spirochetes, and some protozoa. The mechanism of action is that the drug can specifically bind to the A position of the 30S subunit of the bacterial ribosome, preventing the connection of aminoacyl-tRNA at this position, thereby inhibiting the growth of peptide linkage and affecting the synthesis of bacterial proteins.

Cefpodoxime proxetil is an oral broad-spectrum third-generation cephalosporin. After entering the body, it is hydrolyzed into cefpodoxime by nonspecific esterase to exert antibacterial effects. It is effective against both Gram-positive and Gram-negative bacteria. It achieves bactericidal effects by inhibiting the biosynthesis of microbial cell walls. It is stable to beta-lactamase and is still sensitive to many beta-lactamase-producing microorganisms that are resistant to penicillin and cephalosporins. It is ineffective against some ultra-extended-spectrum beta-lactamases.